Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 80,462 |
|
|||||
| News | - | ||||||
| Day High | 0.99 | Low High |
|||||
| Day Low | 0.9309 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MiNK Therapeutics Inc | INKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0052 | -0.53% | 0.9848 | 19:29:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.99 | 0.9309 | 0.99 | 0.9525 | 0.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 444 | 80,462 | $ 0.9653513 | $ 77,674 | - | 0.75 - 3.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:29:15 | formt | 500 | $ 0.9848 | USD |
MiNK Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.79M | 34.52M | - | 0 | -22.46M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiNK Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.86 | 0.99 | 0.86 | 0.9267677 | 40,126 | 0.1248 | 14.51% |
| 1 Month | 0.95 | 1.90 | 0.86 | 1.31 | 196,577 | 0.0348 | 3.66% |
| 3 Months | 0.95 | 1.90 | 0.78 | 1.17 | 102,335 | 0.0348 | 3.66% |
| 6 Months | 1.03 | 1.90 | 0.75 | 1.11 | 72,301 | -0.0452 | -4.39% |
| 1 Year | 1.87 | 3.34 | 0.75 | 1.49 | 98,772 | -0.8852 | -47.34% |
| 3 Years | 12.04 | 22.155 | 0.75 | 3.07 | 112,710 | -11.06 | -91.82% |
| 5 Years | 12.04 | 22.155 | 0.75 | 3.07 | 112,710 | -11.06 | -91.82% |
MiNK Therapeutics Description
| MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. |
